Analysis of Vital Signs in Patients With COVID-19

Completed

• Conditions: Respiratory Disease
• Interventions: Other: Observation of breathing pattern

• Registration Number: NCT04927078
• Lead Sponsor: Oxehealth Limited

Brief Summary

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Detailed Description

The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.

Study Timeline

• Study Start: 2020-04-01
• Primary Completion: 2020-10-31
• Study Completion: 2020-10-31
• Study First Submitted: 2021-04-13
• Status Verified: 2021-06
• Study First Submitted QC: 2021-06-14
• Last Update Submitted: 2021-06-14
• Study First Posted: 2021-06-15
• Last Update Posted: 2021-06-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.

Exclusion Criteria

Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Participants with COVID 19 diagnosis	Observation of breathing pattern	We will measure the breathing rate (BR) before and after the clinical diagnosis of COVID 19.
Participants without COVID 19 diagnosis	Observation of breathing pattern	Breathing rates will be measured for the same time duration as the cases.

Primary Outcome Measures

Name	Time	Method
Breathing rates	Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.	Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

Secondary Outcome Measures

Name	Time	Method
BR and PR	Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.	Similar data to be collected from control subjects
Pulse rates	Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.	Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

Trial Locations

Locations (1)

Coventry and Warwickshire Partnership NHS; 🇬🇧 Coventry, United Kingdom